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Summary Unsafe injection practices, including the re-use of unsterile needles and
syringes, are commonplace in developing country health settings, and contribute
substantially to the global burden of blood-borne viral disease. Unsafe injection
practices place at risk not only patients, but also healthcare workers, who practice
universal precautions inconsistently and are commonly exposed to blood in the course
of their work. Global awareness of the link between unsafe injection practices and the
burden of blood-borne viral disease was slow to emerge but has grown in the recent
years. In 1999, the World Health Organization (WHO) established the Safe Injection
Global Network (SIGN), which advocates a range of interventions for the promotion of
injection safety. As well as exhorting healthcare workers to use a new needle and
syringe for every injection, they should also be encouraged and supported to protect
themselves from exposure to blood. It is argued here that promoting the occupational
safety of healthcare workers in developing countries is an essential and currently
under-valued component of the response to the problem of unsafe injection prac-
tices. Protecting healthcare workers from occupational infection with blood-borne
viruses has a range of potential benefits, including safer injection practices for
patients and less discrimination against people with HIV/AIDS. There is an urgent
need for organisational commitment to the occupational safety of healthcare workers
in developing countries, along with the provision of training in injection safety and
universal precautions, adequate supplies of personal protective equipment, and
hepatitis B vaccination.
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injection and many of these are unsafe.1 In some
countries the proportion of unsafe injections is as
high as 70%.2 Unsafe injection practices, including
the re-use of unsterile needles and syringes in healthes. Published by Elsevier Ltd. All rights reserved.
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hepatitis C, and 5% of HIV infections.3 These prac-
tices place at risk not only patients but also the
healthcare (and other) workers who are required to
handle contaminated injecting equipment in order
to clean and process it for re-use.
Healthcare workers in developing countries
inconsistently practice universal precautions and
are commonly exposed to blood in the course of
their work via needlestick injuries, splash incidents
and direct contact.4 For example, in a cross-sec-
tional survey of 266 north Indian healthcare work-
ers, 63% reported at least one percutaneous injury in
the last year5 compared with 24% in the USA.6 The
risk for healthcare workers in developing countries
is further enhanced by the relatively high preva-
lence of blood-borne viral disease amongst the
patients they care for. In a Zambian study, the risk
of occupational HIV infection amongst surgeons was
estimated to be 15 times greater than surgeons in
Western countries, largely attributable to the fact
that HIV prevalence in the patient population was
22%.7 According to the World Health Organization
(WHO), an estimated 16,000 hepatitis C, 66,000
hepatitis B and 200—5000 HIV infections each year
are caused by occupational exposure to blood. More
than 90% of these infections are occurring in devel-
oping countries, and most are preventable.8
In recent years, global awareness of the link
between unsafe injection practices in developing
countries and the burden of blood-borne viral dis-
ease has grown substantially. In 1999, WHO estab-
lished the Safe Injection Global Network (SIGN),
which is an international alliance of stakeholders
who aim to achieve the safe and appropriate use of
injections worldwide. The SIGN alliance includes
organisations such as UNICEF, UNAIDS and USAID,
governments, NGOs (non-governmental organisa-
tions), universities and industry groups. SIGN pro-
motes three key strategies for achieving injection
safety: 1. Behaviour change among patients and
healthcare workers to decrease injection overuse
and achieve injection safety; 2. The availability of
necessary equipment and supplies; and 3. Safe
management of sharps waste.2
Several approaches to the promotion of injection
safety have been suggested, including the wide-
spread use of auto-disable syringes9 and IEC (infor-
mation, education, communication) campaigns to
make patients more informed consumers of health-
care services.10 However, both of these approaches
have limitations. Even if auto-disable syringes can
be purchased for the same price as standard needles
and syringes and the logistics of distributing them in
remote areas overcome, there remains the thorny
issue of safe waste disposal, and healthcare workersare still at risk because even though the syringe is
disabled after use, the needle remains exposed.
Campaigns to make patients more informed con-
sumers of healthcare services are worthy, but will
have limited impact on injection safety practices
unless injection providers are also targeted. For
example, it has been suggested that patients should
be encouraged to witness needles and syringes being
removed from sealed packets prior to consenting to
an injection,10 but rarely are patients in developing
countries empowered to make such demands of
their healthcare providers. Certainly, those most
likely to encounter unsafe injection practices, i.e.
the rural poor in countries such as India and Africa,
are in no position to dictate the practices of health-
care providers.11 Additionally, patients enter into a
relationship of trust with healthcare providers. If
they did not trust the person they were consulting,
then they would be unlikely to consult them. If a
healthcare provider assures the patient that the
needle and syringe is ‘sterile’, then the patient is
likely to accept the judgement of the trusted expert
(whether they are a poor illiterate farmer in India or
an affluent educated lawyer in Australia) — this is
the nature of the relationship. Patients are also
unlikely to have the knowledge required to make
an informed judgement about the adequacy of ster-
ilisation processes. Healthcare workers have much
greater control over the injection encounter and are
far better placed to influence the quality of the
service and should therefore be the major focus of
campaigns to promote injection safety. However,
they should not only be exhorted to protect their
patients by using a new needle and syringe for every
injection but also to protect themselves from expo-
sure to blood.
It is argued here that promoting the occupational
safety of healthcare workers in developing countries
is an essential and under-valued component of the
response to the problem of unsafe injection prac-
tices. The extent to which injection safety and
healthcare worker safety are inextricably linked
has not been fully appreciated. Healthcare workers
will not take the risks for their patients seriously
(and change their practices accordingly) until they
take the risks to themselves seriously. They cannot
be expected to conscientiously use a new needle
and syringe for every injection (when they have
been doing otherwise for decades), while at the
same time ignoring the fact that they themselves
are frequently being exposed to blood, and nothing
is being done to protect them. Injection safety will
never be achieved if we do not concurrently attend
to the safety of those providing the injections.
Protecting healthcare workers from occupational
infection with blood-borne viruses has many
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healthcare workers will become ill. Not only is it
an essential component of achieving injection
safety for patients, but also one of the keys to
minimising discrimination against patients with
HIV/AIDS. If healthcare workers feel protected from
the risk of occupational infection with blood-borne
viruses such as HIV, they are less likely to discrimi-
nate against infected patients.12 Discrimination
against people with HIV/AIDS is associated with a
range of negative consequences for the individual,
their family and the community generally.13 Addi-
tionally, informed healthcare workers are in a better
position to lead community education regarding
safe injection practices. There is an urgent need
to provide healthcare workers in developing coun-
tries with training in injection safety and the prac-
tice of universal precautions, an adequate supply
of personal protective equipment, and hepatitis B
vaccination. However, these strategies alone will
not be enough. Organisational commitment to injec-
tion and healthcare worker safety is also essential,
as even well-informed, well-intentioned healthcare
workers cannot practice safely unless the environ-
ment in which they are working makes it possible for
them to do so.
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